Structure-based screening and optimization of cytisine derivatives as inhibitors of the menin-MLL interaction

被引:28
作者
Zhong, Hai-Jing [1 ]
Lee, Bo Ra [3 ]
Boyle, Joshua William [3 ]
Wang, Wanhe [2 ]
Ma, Dik-Lung [2 ]
Chan, Philip Wai Hong [3 ,4 ]
Leung, Chung-Hang [1 ]
机构
[1] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
[2] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China
[3] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia
[4] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England
基金
中国国家自然科学基金; 澳大利亚研究理事会;
关键词
HISTONE MODIFICATIONS; LEUKEMIA; PROTEINS; DISCOVERY; FAMILY; CANCER; GENES; SET1;
D O I
10.1039/c6cc01079b
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The natural product-like compound 1 was identified as a direct inhibitor of the menin-MLL interaction by in silico screening. Structure-based optimization furnished analogue 1a, which showed significantly higher potency than both the lead structure 1 and the reference compound MI-2.
引用
收藏
页码:5788 / 5791
页数:4
相关论文
共 25 条
[1]   Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo [J].
Borkin, Dmitry ;
He, Shihan ;
Miao, Hongzhi ;
Kempinska, Katarzyna ;
Pollock, Jonathan ;
Chase, Jennifer ;
Purohit, Trupta ;
Malik, Bhavna ;
Zhao, Ting ;
Wang, Jingya ;
Wen, Bo ;
Zong, Hongliang ;
Jones, Morgan ;
Danet-Desnoyers, Gwenn ;
Guzman, Monica L. ;
Talpaz, Moshe ;
Bixby, Dale L. ;
Sun, Duxin ;
Hess, Jay L. ;
Muntean, Andrew G. ;
Maillard, Ivan ;
Cierpicki, Tomasz ;
Grembecka, Jolanta .
CANCER CELL, 2015, 27 (04) :589-602
[2]   Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies? [J].
Cierpicki, Tomasz ;
Grembecka, Jolanta .
IMMUNOLOGICAL REVIEWS, 2015, 263 (01) :279-301
[3]   Challenges and opportunities in targeting the menin- MLL interaction [J].
Cierpicki, Tomasz ;
Grembecka, Jolanta .
FUTURE MEDICINAL CHEMISTRY, 2014, 6 (04) :447-462
[4]   The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma [J].
Gao, Shu-Bin ;
Xu, Bin ;
Ding, Li-Hong ;
Zheng, Qi-Lin ;
Zhang, Li ;
Zheng, Qi-Fan ;
Li, Shan-Hua ;
Feng, Zi-Jie ;
Wei, Jie ;
Yin, Zhen-Yu ;
Hua, Xianxin ;
Jin, Guang-Hui .
JOURNAL OF HEPATOLOGY, 2014, 61 (04) :832-839
[5]  
Grembecka J, 2012, NAT CHEM BIOL, V8, P277, DOI [10.1038/NCHEMBIO.773, 10.1038/nchembio.773]
[6]   High-Affinity Small-Molecule Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction Closely Mimic a Natural Protein-Protein Interaction [J].
He, Shihan ;
Senter, Timothy J. ;
Pollock, Jonathan ;
Han, Changho ;
Upadhyay, Sunil Kumar ;
Purohit, Trupta ;
Gogliotti, Rocco D. ;
Lindsley, Craig W. ;
Cierpicki, Tomasz ;
Stauffer, Shaun R. ;
Grembecka, Jolanta .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (04) :1543-1556
[7]   Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential [J].
Juan Bayo ;
Dalvi, Maithili P. ;
Martinez, Elisabeth D. .
FUTURE MEDICINAL CHEMISTRY, 2015, 7 (16) :2243-2261
[8]   MLL translocations, histone modifications and leukaemia stem-cell development [J].
Krivtsov, Andrei V. ;
Armstrong, Scott A. .
NATURE REVIEWS CANCER, 2007, 7 (11) :823-833
[9]   Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening [J].
Liu, L-J ;
Leung, K-H ;
Chan, D. S-H ;
Wang, Y-T ;
Ma, D-L ;
Leung, C-H .
CELL DEATH & DISEASE, 2014, 5 :e1293-e1293
[10]   Virtual screening and optimization of Type II inhibitors of JAK2 from a natural product library [J].
Ma, Dik-Lung ;
Chan, Daniel Shiu-Hin ;
Wei, Guo ;
Zhong, Hai-Jing ;
Yang, Hui ;
Leung, Lai To ;
Gullen, Elizabeth A. ;
Chiu, Pauline ;
Cheng, Yung-Chi ;
Leung, Chung-Hang .
CHEMICAL COMMUNICATIONS, 2014, 50 (90) :13885-13888